McPhee, Fiona <br/><br/>
Effect of minor populations of NS5A and NS5B resistance-associated variants on HCV genotype-3 response to daclatasvir plus sofosbuvir, with or without ribavirin.  [electronic resource] 

 -  Antiviral therapy  2017 
 - 237-246 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP3120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Amino Acid Substitution<br/>Antiviral Agents--therapeutic use<br/>Carbamates<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Polymorphism, Genetic<br/>Pyrrolidines<br/>Ribavirin--therapeutic use<br/>Sequence Analysis, DNA<br/>Sofosbuvir--therapeutic use<br/>Treatment Failure<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load<br/>Viral Nonstructural Proteins--genetics